Hjem › Kardiomyopati › Ohio
Kardiomyopati kliniske forsøg i Ohio
6 studier for Kardiomyopati søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Cleveland
- Clinical Trial Site, Columbus
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 16. sep. 2026 · NCT07052903Clinical Course Of Disease In Participants With FA-CM
- Cincinnati Children's Hospital, Cincinnati
RekruttererObservationsstudie
Alder 6 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT06865482Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Cleveland Clinic, Cleveland
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 4. aug. 2026 · NCT06563895Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
- Nationwide Children's, Columbus
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. jul. 2026 · NCT07674758The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
- Cleveland Clinic, Cleveland
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 14. jul. 2026 · NCT05034432MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Cleveland Clinic, Cleveland
- Ohio Health Research Institute, Columbus
RekruttererFase 3
Alder 18 til 90 · Alle køn · Opdateret 27. mar. 2026 · NCT06128629Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.